Influence of Pretreatment with Amphotericin B on Treatement-Related Mortality (TRM) Following Allogeneic Stem Cell Transplantations

MLA

Dietrich W. Beelen, et al. “Influence of Pretreatment with Amphotericin B on Treatement-Related Mortality (TRM) Following Allogeneic Stem Cell Transplantations.” Blood, vol. 104, Nov. 2004, p. 5049. EBSCOhost, https://doi.org/10.1182/blood.v104.11.5049.5049.

APA

Dietrich W. Beelen, Micheal Flasshove, Helmut Ottinger, Rudolf Trenschel, Ahmet H. Elmaagacli, Markus Ditschkowski, Michal Hlinka, & Nina K. Steckel. (2004). Influence of Pretreatment with Amphotericin B on Treatement-Related Mortality (TRM) Following Allogeneic Stem Cell Transplantations. Blood, 104, 5049. https://doi.org/10.1182/blood.v104.11.5049.5049

Chicago

Dietrich W. Beelen, Micheal Flasshove, Helmut Ottinger, Rudolf Trenschel, Ahmet H. Elmaagacli, Markus Ditschkowski, Michal Hlinka, and Nina K. Steckel. 2004. “Influence of Pretreatment with Amphotericin B on Treatement-Related Mortality (TRM) Following Allogeneic Stem Cell Transplantations.” Blood 104 (November): 5049. doi:10.1182/blood.v104.11.5049.5049.